Takayanagi I, Koike K, Noguchi R, Ogishima M, Takiguchi F, Sato T
Department of Chemical Pharmacology, Toho University School of Pharmaceutical Sciences, Chiba, Japan.
Arch Int Pharmacodyn Ther. 1987 Sep;289(1):106-17.
The pD2-values for noradrenaline obtained from the veins of the body wall were quite different from those embryogenetically related to the digestive tract. Therefore, the difference in the post-junctional alpha 1-adrenoceptor mechanism was studied in venous smooth muscle preparations from the canine. The helical and longitudinal strips of the lateral saphenous, femoral and portal veins, and the inferior vena cava were prepared and set in an organ bath apparatus. The longitudinal strips of the lateral saphenous and femoral veins, and inferior vena cava did not or little respond to noradrenaline. The pD2-values for noradrenaline differed considerably among the veins, while the pA2-values for prazosin against noradrenaline were identical in all veins used. Negative log of dissociation constants, pKA-values, for noradrenaline obtained by the partial irreversible blockade of alpha 1-adrenoceptors with phenoxybenzamine were very similar in all the veins. Efficacies which were calculated by the same method differed considerably among the veins. The dissociation constants, KD-value and the maximum binding sites, Bmax-values for [3H]-prazosin were also estimated by Scatchard analysis of the specific binding of [3H]-prazosin to the microsomal fractions from veins. The KD-values for [3H]-prazosin were also identical. However, Bmax-values varied considerably among the veins. The Bmax-values are proportional to the 50% effective concentrations, whose negative logs were the pD2-values, and to the efficacies. The present results suggest that the regional difference in the pD2-values for noradrenaline in the canine veins is not due to the affinities to the alpha 1-adrenoceptors but to the receptor densities.
从体壁静脉获得的去甲肾上腺素的pD2值与那些在胚胎发育上与消化道相关的pD2值有很大不同。因此,研究了犬静脉平滑肌制剂中节后α1 -肾上腺素能受体机制的差异。制备了大隐静脉、股静脉、门静脉和下腔静脉的螺旋条和纵条,并将其置于器官浴装置中。大隐静脉、股静脉和下腔静脉的纵条对去甲肾上腺素无反应或反应很小。不同静脉中去甲肾上腺素的pD2值差异很大,而在所有使用的静脉中,哌唑嗪对去甲肾上腺素的pA2值是相同的。用酚苄明部分不可逆地阻断α1 -肾上腺素能受体所获得的去甲肾上腺素的解离常数的负对数(pKA值)在所有静脉中非常相似。用相同方法计算的效能在不同静脉中差异很大。还通过对[3H] -哌唑嗪与静脉微粒体部分的特异性结合进行Scatchard分析,估计了[3H] -哌唑嗪的解离常数(KD值)和最大结合位点(Bmax值)。[3H] -哌唑嗪的KD值也是相同的。然而,Bmax值在不同静脉中差异很大。Bmax值与50%有效浓度成正比,其负对数即为pD2值,也与效能成正比。目前的结果表明,犬静脉中去甲肾上腺素pD2值的区域差异不是由于对α1 -肾上腺素能受体的亲和力,而是由于受体密度。